Xcout Intel
Kite, a Gilead Company
Kite is a global biopharmaceutical company based in Santa Monica, California, that specializes in developing innovative cell therapies to treat and potentially cure cancer.
Subscribe to see Kite, a Gilead Company’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kite, a Gilead Company at a glance
Kite, a Gilead Company is a biotechnology company headquartered in United States. Xcout tracks 11 named people at Kite, a Gilead Company, including Cindy Perettie (Executive Vice President, Kite).
Kite, a Gilead Company leadership
- Cindy PerettieExecutive Vice President, Kite
- Brian HeathCommercial
- Dominique Tonelli, MDMedical Affairs
- Gallia Levy, MD, PhDDevelopment
- Joe SpieglerLegal
- Kevin CognettiCorporate Strategy
5 more named people on record for Kite, a Gilead Company, with roles, board committees and tenure — see the full roster →
Kite, a Gilead Company competitors
A few of Kite, a Gilead Company's closest competitors — see the full list of competitors and alternatives →
Interius BioTherapeutics is a clinical-stage biotechnology company that engineers targeted, programmable vectors for the precision delivery of genetic medicines. The company develops off-the-shelf CAR T-cell therapies and chimeric antigen receptors intended to treat hematologic malignancies and cancer. Interius BioTherapeutics operates as a subsidiary of Kite, a Gilead company.
Century Therapeutics is an innovative biotechnology company headquartered in Philadelphia, Pennsylvania. Its mission is to develop allogeneic, iPSC-derived NK and T cell therapies that are designed to be more effective, tolerable, and accessible.
Established in 2015 and based in Minato, Japan, this company is dedicated to exploring and advancing CAR-T cell technology for use in cancer immunotherapy treatments.
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.
Bellicum Pharmaceuticals, Inc. is a company focused on engineering high-performance cellular immunotherapies. These therapies are developed to combat diseases.
Orca Bio is a late-stage biotechnology company developing high-precision cell therapies. These therapies are designed for the treatment of cancer and autoimmune diseases, with a facility located in Sacramento.
Get Kite, a Gilead Company's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Kite, a Gilead Company in Xcout Intel
- 11 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access